EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY. Int. Res. J. Pharm. 2024, 15 (6), 35-39.